- Demineralized bone matrix is an allograft bone material processed to remove minerals while retaining growth factors that promote bone regeneration. It is widely used in orthopedic, spinal, and dental procedures to enhance bone healing
- The global DBM market is projected to grow at a CAGR of 5.44%, driven by the rising prevalence of orthopedic disorders, increasing geriatric population, and advancements in regenerative medicine. The demand for minimally invasive procedures and biocompatible graft materials further supports market expansion. In addition, favorable reimbursement policies and heightened awareness of bone graft alternatives are fueling growth
- For instance, In January 2024, a major biotechnology firm introduced an advanced DBM product with enhanced osteoinductive properties, reflecting ongoing innovation in the sector. North America dominates the market due to its well-established healthcare infrastructure and high adoption rates, while the Asia-Pacific region is witnessing rapid growth due to rising healthcare investments
- However, challenges such as high costs and regulatory constraints may hinder market expansion. Despite this, continued R&D and strategic partnerships are expected to sustain market momentum in the coming years
